Market revenue in 2023 | USD 239.5 million |
Market revenue in 2030 | USD 625.3 million |
Growth rate | 14.7% (CAGR from 2023 to 2030) |
Largest segment | Ablation catheters |
Fastest growing segment | Ablation Catheters |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diagnostic Catheters, Laboratory Devices, Access Devices, Ablation Catheters |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Abbott Laboratories, Johnson & Johnson, BIOTRONIK, GE Aerospace, Siemens Healthineers AG ADR, MicroPort Scientific Corp, Koninklijke Philips NV |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to electrophysiology devices market will help companies and investors design strategic landscapes.
Ablation catheters was the largest segment with a revenue share of 43.88% in 2024. Horizon Databook has segmented the Australia electrophysiology devices market based on diagnostic catheters, laboratory devices, access devices, ablation catheters covering the revenue growth of each sub-segment from 2018 to 2030.
CVDs, including conditions such as AFib, VT, and other arrhythmias, are prevalent in Australia. These conditions can lead to adverse health outcomes, including strokes and sudden cardiac death. According to the Australian Institute of Health and Welfare, CVD was the underlying cause of 42,700 deaths (25% of all deaths) in 2021.
As a result, there is a growing demand for EP devices to diagnose and manage these cardiac arrhythmias. The government in Australia actively supports the advancement of cardiovascular devices by providing financial assistance to accelerate clinical trials.
For instance, in February 2021, a grant of USD 200,000 was awarded to the Australian Cardiovascular Alliance (ACvA) to enhance Australia’s involvement in these trials.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia electrophysiology devices market, including forecasts for subscribers. This country databook contains high-level insights into Australia electrophysiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account